Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinical deep-dive into retatrutide's delayed-onset side effects, from gallbladder disease to heart-rate changes, with trial data, dosing timelines, and monitoring guidance.
Read clinical reviewA complete breakdown of retatrutide adverse event incidence rates drawn from Phase 2 dose-escalation data, the TRIUMPH program, and available post-market surveillance. Reviewed by the HealthRX medical team.
Read clinical reviewA clinician-reviewed breakdown of retatrutide side effects, including which adverse events may be long-lasting or irreversible, based on phase 2 trial data, FAERS reports, and published literature.
Read clinical reviewA physician-reviewed breakdown of the rare but serious adverse events linked to retatrutide, drawing on Phase 2 trial data, FAERS signals, and emerging post-market reports.
Read clinical reviewA comprehensive clinical breakdown of retatrutide adverse events by severity grade and patient phenotype, drawing on Phase 2 trial data, FAERS signals, and endocrine-society guidance.
Read clinical reviewA clinician-reviewed guide to retatrutide withdrawal and discontinuation syndrome, covering what happens when you stop the drug, which symptoms to expect, how long they last, and how to taper safely based on Phase 2 trial data.
Read clinical review